Study results indicate that mutation strength may shape both tumor–immune system interactions and immunotherapy response.
The illustration of protein structure (domains) on the left side, and corresponding exons in the FLT3 gene are displayed on the right side. FMS-like tyrosine kinase 3 (FLT3) mutations represent some ...